Akebia Therapeutics Stock Forecast

Sell candidate since Jul 20, 2026 Gain 1.56%

The Akebia Therapeutics stock price gained 1.56% on the last trading day (Tuesday, 21st Jul 2026), rising from $1.28 to $1.30. During the last trading day the stock fluctuated 4.72% from a day low at $1.27 to a day high of $1.33. The price has been going up and down for this period, and there has been a -4.41% loss for the last 2 weeks. Volume fell on the last day by -1 million shares and in total, 2 million shares were bought and sold for approximately $2.28 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.42% during the next 3 months and, with a 90% probability hold a price between $0.84 and $1.39 at the end of this 3-month period.

AKBA Signals & Forecast

The Akebia Therapeutics stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $1.35. On a fall, the stock will find some support from the long-term average at approximately $1.14. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -9.09%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Akebia Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.18 and $1.07. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Akebia Therapeutics finds support just below today's level at $1.18. If this is broken, then the next support from accumulated volume will be at $1.07 and $1.01.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0600 between high and low, or 4.72%. For the last week, the stock has had daily average volatility of 5.29%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AKBA) For The Upcoming Trading Day Of Wednesday 22nd

For the upcoming trading day on Wednesday, 22nd we expect Akebia Therapeutics to open at $1.30, and during the day (based on 14 day Average True Range), to move between $1.26 and $1.34, which gives a possible trading interval of +/-$0.0780 (+/-6.18%) up or down from last closing price. If Akebia Therapeutics takes out the full calculated possible swing range there will be an estimated 6.18% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.40 (7.69%) than the support at $1.18 (9.23%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Akebia Therapeutics stock A Buy?

Akebia Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.372 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 22, 2026 - $1.30 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk